A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.
bioRxiv
; 2023 Jun 07.
Article
en En
| MEDLINE
| ID: mdl-37333335
Texto completo:
1
Colección:
01-internacional
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Revista:
BioRxiv
Año:
2023
Tipo del documento:
Article